Breart B, Williams K, Krimm S, Wong T, Kayser B, Wang L
Nature. 2025; .
PMID: 39910298
DOI: 10.1038/s41586-024-08510-w.
Yazdanpanah E, Pazoki A, Dadfar S, Nemati M, Sajad Siadati S, Tarahomi M
Biomolecules. 2025; 14(12.
PMID: 39766196
PMC: 11672993.
DOI: 10.3390/biom14121489.
Lee Y, Lee R, Kim J, Han Y, Hunter C, Park J
BMC Vet Res. 2024; 20(1):429.
PMID: 39334332
PMC: 11438354.
DOI: 10.1186/s12917-024-04287-2.
Zhao S, Hu X, Lin X, Zhang Y, Wang J, Wang H
JCI Insight. 2024; 9(16).
PMID: 39171524
PMC: 11343602.
DOI: 10.1172/jci.insight.179233.
Al-Danakh A, Safi M, Jian Y, Yang L, Zhu X, Chen Q
Front Immunol. 2024; 15:1348189.
PMID: 38590525
PMC: 11000233.
DOI: 10.3389/fimmu.2024.1348189.
An updated advancement of bifunctional IL-27 in inflammatory autoimmune diseases.
Xu W, Wang D, Zhao M, Huang A
Front Immunol. 2024; 15:1366377.
PMID: 38566992
PMC: 10985211.
DOI: 10.3389/fimmu.2024.1366377.
TCR Signals Controlling Adaptive Immunity against Toxoplasma and Cancer.
Okamoto M, Yamamoto M
Adv Exp Med Biol. 2024; 1444:177-193.
PMID: 38467980
DOI: 10.1007/978-981-99-9781-7_12.
Targeting the NF-κB pathway as a potential regulator of immune checkpoints in cancer immunotherapy.
Ebrahimi N, Abdulwahid A, Mansouri A, Karimi N, Bostani R, Beiranvand S
Cell Mol Life Sci. 2024; 81(1):106.
PMID: 38418707
PMC: 10902086.
DOI: 10.1007/s00018-023-05098-8.
LAG-3, TIM-3, and TIGIT: Distinct functions in immune regulation.
Joller N, Anderson A, Kuchroo V
Immunity. 2024; 57(2):206-222.
PMID: 38354701
PMC: 10919259.
DOI: 10.1016/j.immuni.2024.01.010.
Prognostic utility of TME-associated genes in pancreatic cancer.
Nie Y, Xu L, Bai Z, Liu Y, Wang S, Zeng Q
Front Genet. 2023; 14:1218774.
PMID: 37727377
PMC: 10505756.
DOI: 10.3389/fgene.2023.1218774.
The Interaction of Borrelia burgdorferi with Human Dendritic Cells: Functional Implications.
Gutierrez-Hoffmann M, Fan J, OMeally R, Cole R, Florea L, Antonescu C
J Immunol. 2023; 211(4):612-625.
PMID: 37405694
PMC: 10527078.
DOI: 10.4049/jimmunol.2300235.
Hierarchical transcriptional network governing heterogeneous T cell exhaustion and its implications for immune checkpoint blockade.
Tian W, Qin G, Jia M, Li W, Cai W, Wang H
Front Immunol. 2023; 14:1198551.
PMID: 37398674
PMC: 10311999.
DOI: 10.3389/fimmu.2023.1198551.
Tackling of Immunorefractory Tumors by Targeting Alternative Immune Checkpoints.
Dulal D, Boring A, Terrero D, Johnson T, Tiwari A, Raman D
Cancers (Basel). 2023; 15(10).
PMID: 37345111
PMC: 10216651.
DOI: 10.3390/cancers15102774.
IL-12 and IL-27 Promote CD39 Expression on CD8+ T Cells and Differentially Regulate the CD39+CD8+ T Cell Phenotype.
Gerhardt L, Hong M, Yousefi Y, Figueredo R, Maleki Vareki S
J Immunol. 2023; 210(10):1598-1606.
PMID: 37000461
PMC: 10152038.
DOI: 10.4049/jimmunol.2200897.
Peripheral PD-1 and Tim-3 percentages are associated with primary sites and pathological types of peritoneal neoplasms.
Hu H, Zhao J, Yuan J, Zhang M
BMC Cancer. 2023; 23(1):287.
PMID: 36991376
PMC: 10052833.
DOI: 10.1186/s12885-023-10752-2.
Structural basis of activation and antagonism of receptor signaling mediated by interleukin-27.
Skladanowska K, Bloch Y, Strand J, White K, Hua J, Aldridge D
Cell Rep. 2022; 41(3):111490.
PMID: 36261006
PMC: 9597551.
DOI: 10.1016/j.celrep.2022.111490.
Emerging Targets in Clear Cell Renal Cell Carcinoma.
Chen Y, Rini B, Beckermann K
Cancers (Basel). 2022; 14(19).
PMID: 36230766
PMC: 9561986.
DOI: 10.3390/cancers14194843.
Structural insights into the assembly and activation of the IL-27 signaling complex.
Jin Y, Fyfe P, Gardner S, Wilmes S, Bubeck D, Moraga I
EMBO Rep. 2022; 23(10):e55450.
PMID: 35920255
PMC: 9535766.
DOI: 10.15252/embr.202255450.
Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer.
Jia K, Chen Y, Sun Y, Hu Y, Jiao L, Ma J
BMC Med. 2022; 20(1):223.
PMID: 35811317
PMC: 9272556.
DOI: 10.1186/s12916-022-02421-1.
Impact of secondary TCR engagement on the heterogeneity of pathogen-specific CD8+ T cell response during acute and chronic toxoplasmosis.
Shallberg L, Phan A, Christian D, Perry J, Haskins B, Beiting D
PLoS Pathog. 2022; 18(6):e1010296.
PMID: 35727849
PMC: 9249239.
DOI: 10.1371/journal.ppat.1010296.